CELZ
NASD Creative Medical Technology Holdings, Inc.$0.9464 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.9464, $0.0236 below the day’s high of $0.9700
- YTD change
- -51.71%
- vs 20-day SMA
- -2.43%
- vs 200-day SMA
- -44.80%
Price ranges
Price & Performance
-1.19 (-55.78%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 98.2% away from all-time highs of $51.4500
- CELZ is down 52% since the beginning of the year
- CELZ is down 70% over the past 12 months
- CELZ is down 16% over the past 1 month
- 1% of all CELZ investors are betting against CELZ
CELZ reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -70.7%.
- Previous minute
- +$0.0000
- Last hour
- -$0.0061
- Last 5 days
- -2.43%
- vs 8-day SMA
- -2.50%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Creative Medical Technology Holdings, Inc. is a commercial stage biotechnology company which focuses on regenerative therapies in the fields of immunotherapy, endocrinology, urology, neurology and orthopedics. Its products include CaverStem, FemCelz, StemSpine and ImmCelz. The company was founded by Timothy Warbington on December 3, 1998 and is headquartered in Phoenix, AZ.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.